TFII-I activators encompass a diverse range of chemical compounds that influence the activity of the General Transcription Factor II-I, either directly or more commonly, indirectly. These activators work through various cellular mechanisms, influencing signaling pathways and cellular processes that converge on TFII-I regulation. For instance, compounds like EGCG and Resveratrol exert their effects by modulating kinase pathways or altering gene expression patterns, which indirectly impact TFII-I. Others, like Forskolin and Ionomycin, work through changes in intracellular second messengers such as cAMP and calcium ions, respectively. This indirect modulation highlights the complexity of TFII-I regulation and the intricate network of cellular signals that control its activity.
Further exploring these activators, we see that many, such as Sodium Butyrate, TSA, and Rapamycin, function through epigenetic mechanisms or by modulating key cellular kinases and phosphatases. The diversity in the chemical nature and mechanism of action of these activators underscores the multifaceted role of TFII-I in cellular physiology. By influencing TFII-I, these chemicals can potentially affect a broad array of cellular processes, from gene expression and DNA repair to cell cycle regulation and response to cellular stress. The study of these activators not only provides insight into the regulatory mechanisms governing TFII-I activity but also opens up potential avenues for manipulating these pathways in various biological contexts. The understanding of TFII-I activators, therefore, represents a significant step in comprehending the broader landscape of gene regulation and cellular signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a catechin found in green tea, can modulate TFII-I activity indirectly by influencing cellular signaling pathways such as the ERK pathway, which in turn can affect TFII-I activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an activator of adenylate cyclase, increases cAMP levels in cells, indirectly influencing TFII-I activity through cAMP-responsive elements. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can modulate TFII-I activity indirectly by phosphorylating it or altering its subcellular localization. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin, a calcium ionophore, can indirectly affect TFII-I activity by altering intracellular calcium levels, which play a role in TFII-I mediated signaling pathways. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a histone deacetylase inhibitor, can indirectly influence TFII-I activity by altering chromatin structure and gene expression patterns. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, can influence TFII-I activity indirectly by affecting the PI3K/Akt pathway, which interacts with TFII-I regulatory mechanisms. | ||||||